Syntegra Closes $5.625 Million in Seed Funding

<p><strong><span class&equals;"xn-location">SAN FRANCISCO<&sol;span><&sol;strong> &&num;8212&semi; <u>Syntegra<&sol;u>&comma; a leader in synthetic healthcare data generation&comma; has closed its seed financing&comma; bringing in a total of <span class&equals;"xn-money">&dollar;5&period;625 million<&sol;span>&period; Syntegra&&num;8217&semi;s investors include Sweat Equity Ventures&comma; Hike Ventures&comma; Innovation Global Capital&comma; Wisconn Valley Ventures&comma; Village Global&comma; Impact Venture Capital&comma; GRIDS Capital&comma; Berkeley Catalyst Fund&comma; Launchpad Capital&comma; Vastly Valuable Ventures and First Spark Ventures&period;<&sol;p>&NewLine;<p>The funding will allow Syntegra to commercialize new and ongoing work with health systems&comma; payers&comma; life science and digital health companies&comma; advancing data-driven innovation with its synthetic data solutions&period; It will also enable the growth of the Syntegra Medical Mind&comma; the company&&num;8217&semi;s ever-expanding&comma; pre-trained model&comma; which has now trained on over 10 million records and enables the creation of built-for-purpose synthetic datasets&period;<&sol;p>&NewLine;<p>In the past year&comma; Syntegra reports it has more than tripled its customer base and partnered with key leaders in healthcare&comma; technology and data privacy to explore the nearly endless possibilities for synthetic healthcare data in clinical research&comma; analytics and AI model development&period;<&sol;p>&NewLine;<p>&&num;8220&semi;Synthetic data has the potential to dramatically transform the way clinical information is shared and utilized by multiple researchers in healthcare&comma;&&num;8221&semi; said <span class&equals;"xn-person">Michael D&period; Lesh<&sol;span>&comma; SM MD FACC&comma; Syntegra Founder and CEO&period; &&num;8220&semi;This funding provides Syntegra with the capital required to fulfill our mission of accelerating innovation by making data more easily available to researchers&period; The investors we have chosen all add strategic insights that multiply the value of the capital&period;&&num;8221&semi;<&sol;p>&NewLine;<p>&&num;8220&semi;Synthetic data is at the forefront of innovation and change in healthcare&comma;&&num;8221&semi; said <span class&equals;"xn-person">Guy Perelmuter<&sol;span>&comma; Founder&comma; GRIDS Capital&period; &&num;8220&semi;We&&num;8217&semi;re excited to back the Syntegra team and their distinctive&comma; AI-enabled approach to synthetic data generation&comma; which holds tremendous potential to unlock the vast amounts of data held up in silos across the healthcare industry that can be used to accelerate research and analytics&period;&&num;8221&semi;<&sol;p>&NewLine;<p>&&num;8220&semi;Syntegra is addressing a major challenge in healthcare today – bridging the gap between data access and data privacy to enable greater use of data that will bring more medical advances directly to patients&comma;&&num;8221&semi; said <span class&equals;"xn-person">Daniel Portillo<&sol;span>&comma; Founder and Managing Partner&comma; Sweat Equity Ventures&period; &&num;8220&semi;We&&num;8217&semi;re thrilled to be working closely with Syntegra as they advance their vision of democratizing healthcare data through their groundbreaking approach to synthetic data generation&period;&&num;8221&semi;<&sol;p>&NewLine;